Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

Kelly Maree Chipperfield, Jane Madeline Fletcher, Jeremy Millar, Joanne Elizabeth Brooker, Robin Smith, Mark Frydenberg, Susan Burney

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

To evaluate the effects of androgen deprivation therapy (ADT) on depression, anxiety and quality of life (QoL) in patients with prostate cancer (PCa) and to examine the relationship between meeting the National Physical Activity Guidelines of Australia (NPAGA) and the presence and severity of both psychological sequelae and physical side effects associated with ADT. A secondary purpose was to examine the predictors of depression, anxiety and QoL in patients with PCa.
Original languageEnglish
Pages (from-to)2169 - 2176
Number of pages8
JournalPsycho-Oncology
Volume22
Issue number10
DOIs
Publication statusPublished - 2013

Cite this